(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
about
sameAs
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude miceComparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replicationAntiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracilAnti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapyAntiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracilsSelective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridineDifferential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinasesInhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virusIn vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsInhibitory effect of E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on herpes simplex virus replication and DNA synthesisA new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 19-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplicationAntiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitisStructure of the Varicella Zoster Virus Thymidylate Synthase Establishes Functional and Structural Similarities as the Human Enzyme and Potentiates Itself as a Target of BrivudineChemotherapeuticsFurano pyrimidines as novel potent and selective anti-VZV agents.Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency.Synthesis and anti-varicella-zoster virus activity of some novel bicyclic nucleoside inhibitors: effect of enhanced aqueous solubility.Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial.Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked studyRandomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulcerationIncidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in SheffieldEffect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in miceEffect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells.Emerging drugs for varicella-zoster virus infections.Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.In search of a selective antiviral chemotherapy.Inactivation of herpes simplex virus types 1 and 2 by synthetic histidine peptides.A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity.Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogsInhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase.Comparative efficacy of antiherpes drugs in different cell lines.Possible molecular basis for antiviral activity of certain 5-substituted deoxyuridines.Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation.Comparison of flow cytometric analysis and [3H]thymidine incorporation for measurement of the effects of drug toxicity on lymphocyte stimulation.Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides
P2860
Q26771734-6B27F5F8-715D-4737-87D8-3D28E1D75444Q28328858-904C543B-44AB-435B-B9B0-C5C0A73FB084Q28359881-7930D72B-601B-427B-98D0-EB0BB9ECA8CBQ28366042-2595B5D7-2F05-4AA3-AEF0-BD49D1F49AFDQ28366092-6729E906-425B-4804-A5F8-410CD88B0CC8Q28366109-C7D2B5E9-4253-491F-B588-4019C3B1AB12Q28366126-5DA1D9D2-F45D-429A-B69C-B2B2D733B67CQ28366136-E55CDA99-F737-4F56-8A16-DF8DA76F9377Q28366145-EA4B43E6-466C-475C-B560-9E0852FA77CAQ28366155-8DEE5CD8-48FB-4E28-B3B4-795D919268DCQ28366169-B6F6EBA0-0BBF-491D-A34D-5A75F6EF4356Q28366181-11D66AD8-6EBF-44FC-B1A5-C353475F3366Q28366232-3E0B3ECF-0FE4-4531-A37D-1E0BD1F148E4Q28366251-88B37D9B-B116-444F-A1CE-2321867DB777Q28366260-BA5C7BAB-0C95-4AB6-906D-EFE37251BB38Q28367048-BC75D545-E531-4D71-A54A-418E7F96ADBFQ28551253-183A552E-F5F3-4FA1-95DA-8211A4BC808BQ30047670-C76ADAAC-81B1-4919-AE5B-52E37CE485A1Q30659427-EBEFBBE2-E2E4-40DC-AFF2-6FE392386754Q31805522-2C71006B-5537-4E25-B0C7-42753617B728Q32066802-FD47739D-34D5-4BEA-8C0D-ECA5FD3D9F09Q33642077-861B0FD7-B7BD-423E-A517-479434C26D32Q33647354-75859B9B-4FE8-46FF-AECC-81132A65AF48Q33649145-C495299D-8BED-4751-9D1E-6D90987630C2Q33658596-7E40A013-D8C3-4B08-9BAC-C3A396B46614Q33723014-A3D5A7F0-E3A0-44B3-B79D-B715137718CFQ33729804-B67EFB37-5347-4873-A34C-C21597D44D4AQ34027426-020176EA-44FF-4A59-AA68-04FA0B44262FQ35266748-127FCD6A-325B-489F-9743-465FBE5C1B47Q35358460-168A9841-F957-448D-8C53-723D46CEA33FQ35375912-1EBC00D1-FCBC-4051-AC9A-C482885DCD0FQ35542515-ECC203F7-1489-453C-BB8B-D5D828126A8BQ35559189-FC1B1325-43B3-4C6B-B389-21D148B29AF6Q35573577-C234DF03-34FD-4CE6-8F4B-CCF01856A1F3Q35669956-CD454D60-E67A-477F-AAB2-7386292885F0Q35675271-21C224F9-7C45-4D21-8DD1-0EA74A5176E2Q35740057-161CB971-2657-4DA5-BE02-2D55BC80DF9CQ35740490-64BEFE1F-5202-4A66-8EBA-60E9FCE3C35BQ35755310-96827F9A-EEB9-4F1A-91BD-58CF06FC5C65Q35759715-8B903414-3FA5-4EF2-8ECB-44951F959354
P2860
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@ast
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@en
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@nl
type
label
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@ast
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@en
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@nl
prefLabel
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@ast
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@en
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@nl
P2093
P2860
P356
P1476
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent
@en
P2093
P2860
P304
P356
10.1073/PNAS.76.6.2947
P407
P577
1979-06-01T00:00:00Z